Jingbin� Huang

856 total citations
34 papers, 627 citations indexed

About

Jingbin� Huang is a scholar working on Molecular Biology, Biomedical Engineering and Organic Chemistry. According to data from OpenAlex, Jingbin� Huang has authored 34 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Biomedical Engineering and 5 papers in Organic Chemistry. Recurrent topics in Jingbin� Huang's work include Nanoplatforms for cancer theranostics (6 papers), Mitochondrial Function and Pathology (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Jingbin� Huang is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Mitochondrial Function and Pathology (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Jingbin� Huang collaborates with scholars based in China. Jingbin� Huang's co-authors include Rong Zhang, Changpeng� Hu, Guobing� Li, Wuyi Liu, Qian Zhang, Qin Tang, Yali Liu, Wenjing Lai, Fangfang Sheng and Huyue Zhou and has published in prestigious journals such as Cancer Research, Applied Catalysis B: Environmental and Oncogene.

In The Last Decade

Jingbin� Huang

30 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingbin� Huang China	14	361	106	101	70	70	34	627
Mingjun Wu China	15	385 1.1×	86 0.8×	84 0.8×	54 0.8×	36 0.5×	37	752
Yutong Li China	15	459 1.3×	113 1.1×	101 1.0×	75 1.1×	44 0.6×	60	830
Aditya Parekh India	12	418 1.2×	108 1.0×	205 2.0×	69 1.0×	64 0.9×	21	738
Huaijiang Yan China	10	518 1.4×	112 1.1×	136 1.3×	75 1.1×	50 0.7×	14	823
Ramya Krishna Vadlapatla United States	19	366 1.0×	67 0.6×	93 0.9×	153 2.2×	85 1.2×	29	878
良樹鷹津 China	15	344 1.0×	96 0.9×	104 1.0×	67 1.0×	43 0.6×	30	869
Diana Aparecida Dias Câmara Brazil	9	211 0.6×	82 0.8×	62 0.6×	49 0.7×	39 0.6×	17	472
You Li China	12	250 0.7×	89 0.8×	46 0.5×	43 0.6×	103 1.5×	29	598

Countries citing papers authored by Jingbin� Huang

Since Specialization

Citations

This map shows the geographic impact of Jingbin� Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingbin� Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingbin� Huang more than expected).

Fields of papers citing papers by Jingbin� Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingbin� Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingbin� Huang. The network helps show where Jingbin� Huang may publish in the future.

Co-authorship network of co-authors of Jingbin� Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingbin� Huang. A scholar is included among the top collaborators of Jingbin� Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingbin� Huang. Jingbin� Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Yi, Wenxue Li, Jingbin� Huang, et al.. (2025). Electrooxidation-induced arylsulfonylation of xanthene derivatives with DABSO as an SO ₂ surrogate. Organic & Biomolecular Chemistry. 23(21). 5081–5085.

Huang, Jingbin�, Yafeng Liu, Yuying Huang, et al.. (2025). TBAI-mediated electrochemical oxidative synthesis of quinazolin-4(3 H )-ones from 2-aminobenzamides and isothiocyanates. Organic & Biomolecular Chemistry. 23(20). 4860–4865. 1 indexed citations

Huang, Yue, Kui Wang, Qiang Zhou, et al.. (2025). Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer. Materials Today Bio. 33. 101993–101993. 1 indexed citations

Liu, Shaohua, et al.. (2024). Osmanthus-derived carbon dots for cell imaging and NIR photothermal therapy. Materials Letters. 377. 137347–137347. 6 indexed citations

Ye, Fei, et al.. (2024). Soft tissue infection and osteomyelitis caused by Mycobacterium farcinogenes after heart surgery: Case report and literature review of human cases. Diagnostic Microbiology and Infectious Disease. 108(4). 116191–116191.

Zhou, Qiang, et al.. (2024). Evodiamine encapsulated by hyaluronic acid modified zeolitic imidazolate framework-8 for tumor targeted therapy. Drug Delivery and Translational Research. 15(3). 978–991. 9 indexed citations

Wang, Jie, Fengling Wang, Dandan Xie, et al.. (2023). PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases. Pharmaceutics. 15(2). 349–349. 3 indexed citations

Zhou, Min, Wenjing Lai, Rufu Xu, et al.. (2023). A celastrol-based nanodrug with reduced hepatotoxicity for primary and metastatic cancer treatment. EBioMedicine. 94. 104724–104724. 18 indexed citations

Liu, Yali, Wuyi Liu, Guobing� Li, et al.. (2023). Cu_2−xSe nanoparticles suppress cell proliferation and migration in hepatocellular carcinoma by impairing mitochondrial respiration. Biomedical Materials. 18(3). 35013–35013.

10.

Zhou, Huyue, Yi Yang, Weilong Shang, et al.. (2022). Pyocyanin biosynthesis protects Pseudomonas aeruginosa from nonthermal plasma inactivation. Microbial Biotechnology. 15(6). 1910–1921. 13 indexed citations

11.

Zhou, Min, Wenjing Lai, Guobing� Li, et al.. (2021). Platelet Membrane-Coated and VAR2CSA Malaria Protein-Functionalized Nanoparticles for Targeted Treatment of Primary and Metastatic Cancer. ACS Applied Materials & Interfaces. 13(22). 25635–25648. 45 indexed citations

12.

Chen, Juan, Huyue Zhou, Jingbin� Huang, Rong Zhang, & Xiancai Rao. (2021). Virulence alterations in staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibiotics. Journal of Advanced Research. 31. 165–175. 50 indexed citations

13.

Huang, Jingbin�, Wenjing Lai, Qing Wang, et al.. (2021). Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles. International Journal of Nanomedicine. Volume 16. 7497–7515. 29 indexed citations

14.

Hu, Changpeng�, Qian Zhang, Qin Tang, et al.. (2019). CBX4 promotes the proliferation and metastasis via regulating BMI‐1 in lung cancer. Journal of Cellular and Molecular Medicine. 24(1). 618–631. 39 indexed citations

15.

Liu, Yali, Guobing� Li, Wenjing Lai, et al.. (2019). Cu_2−xSe nanoparticles (Cu_2−xSe NPs) mediated neurotoxicityviaoxidative stress damage in PC-12 cells and BALB/c mice. RSC Advances. 9(63). 36558–36569. 6 indexed citations

16.

Liu, Wuyi, Qin Tang, Qian Zhang, et al.. (2019). Lycorine Induces Mitochondria-Dependent Apoptosis in Hepatoblastoma HepG2 Cells Through ROCK1 Activation. Frontiers in Pharmacology. 10. 651–651. 24 indexed citations

17.

Liu, Yali, Wuyi Liu, Jingbin� Huang, et al.. (2019). Cu _2-x Se Nanoparticles Enhance the Anticancer Activity of Oxaliplatin By Inhibiting Autophagic Degradation. Nanomedicine. 14(10). 1307–1321. 5 indexed citations

18.

Zhou, Li, Fan Yang, Guobing� Li, et al.. (2018). Coptisine Induces Apoptosis in Human Hepatoma Cells Through Activating 67-kDa Laminin Receptor/cGMP Signaling. Frontiers in Pharmacology. 9. 517–517. 33 indexed citations

19.

Gao, Zhuowei, et al.. (2016). The effects of PK11195 on meningioma was associated with allopregnanolone biosynthesis, which was mediated by translocator protein 18 KDa. Cancer Biomarkers. 16(1). 65–69. 5 indexed citations

20.

Qi, Xiulan, et al.. (2012). Toll-like receptor 4 signaling promotes the immunosuppressive cytokine production of human cervical cancer.. PubMed. 33(3). 291–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact